An evening-focused blend with Blue Lotus, Valerian Root, L-theanine and California Poppy.
$40.00
Ashwagandha · Rhodiola · Holy Basil · Schisandra · Phosphatidylserine
Fern & Lily ADAPTA combines four standardised botanical extracts with 75 mg of actual phosphatidylserine in one precisely specified 500 mg capsule. Created for adults seeking a considered approach to demanding days and intentional downtime, it brings five complementary ingredients together in a convenient daily formula.
$40.00
STARTING AT $0.67 / SERVE
60 capsules
BATCH CERTIFICATE
Download COAEVERY BATCH VERIFIED
Tested in-house
THE ESSENTIALS
When the pace of everyday life calls for a more considered routine, ADAPTA offers a clearly specified combination of botanical extracts and phosphatidylserine.
Each capsule contains standardised extracts of Ashwagandha Root, Rhodiola Root, Holy Basil Leaf and Schisandra Berry. These are complemented by 75 mg of actual phosphatidylserine derived from soy lecithin.
Rather than relying on unspecified botanical powders, ADAPTA discloses the concentration of selected constituents within each extract. This provides greater formulation transparency and helps maintain a more consistent specification from capsule to capsule.
ADAPTA can be incorporated into a morning routine ahead of a demanding day or taken in the evening as part of intentional downtime, depending on individual preference and response.
Adults: Take one to two capsules daily with food, or as directed by a healthcare professional.
For a daytime routine, take in the morning with food before a busy or mentally demanding day.
Alternatively, take with an evening meal as part of a wind-down routine if evening use suits you. Because individual responses to Rhodiola can vary, take the product earlier in the day if evening use affects your sleep.
Do not exceed two capsules daily.
WHAT’S INSIDE
CLEARLY DISCLOSED. NOTHING HIDDEN.
Each capsule contains:
| Ingredient | Amount | Standardisation | Calculated constituent |
|---|---|---|---|
| Ashwagandha Root (Withania somnifera) extract | 125 mg | 5% withanolides | 6.25 mg withanolides |
| Rhodiola Root (Rhodiola rosea) extract | 100 mg | 3% rosavins and 1% salidroside | 3 mg rosavins and 1 mg salidroside |
| Holy Basil Leaf (Ocimum sanctum) extract | 100 mg | 2.5% ursolic acid | 2.5 mg ursolic acid |
| Schisandra Berry (Schisandra chinensis) extract | 100 mg | 3% schisandrin | 3 mg schisandrin |
| Phosphatidylserine from soy lecithin | 75 mg | Actual phosphatidylserine | 75 mg phosphatidylserine |
| Total active ingredients | 500 mg | — | — |
Contains soy.

ADAPTA combines four standardised botanical extracts with 75 mg of actual phosphatidylserine. It offers a broader formula for customers who prefer one multi-ingredient capsule instead of several individual products.
Each capsule provides 75 mg of actual phosphatidylserine derived from soy lecithin.
Yes. The phosphatidylserine is derived from soy lecithin. People with a soy allergy should not use this product.
Standardisation means an extract is produced to contain a defined concentration of a selected constituent. It provides formulation consistency and transparency but does not guarantee a particular outcome.
The formula contains 125 mg of Ashwagandha Root extract standardised to 5% withanolides, providing 6.25 mg per capsule.
Each capsule contains 100 mg of Rhodiola Root extract standardised to 3% rosavins and 1% salidroside, providing 3 mg of rosavins and 1 mg of salidroside.
The formula contains 100 mg of Holy Basil Leaf extract standardised to 2.5% ursolic acid, providing 2.5 mg per capsule.
The formula contains 100 mg of Schisandra Berry extract standardised to 3% schisandrin, providing 3 mg per capsule.
Either may be suitable depending on the individual routine and response:
If evening use affects sleep, take it earlier in the day.
Two capsules provide:
A bottle of 60 capsules provides 60 servings at one capsule or 30 servings at two capsules.
CUSTOMER REVIEWS
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.